These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16018597)

  • 21. Prudent application of radiofrequency ablation in resectable colorectal liver metastasis.
    Bremers AJ; Ruers TJ
    Eur J Surg Oncol; 2007 Aug; 33(6):752-6. PubMed ID: 17408907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Total pelvic exenteration for primary locally advanced and locally recurrent rectal cancer.
    Vermaas M; Ferenschild FT; Verhoef C; Nuyttens JJ; Marinelli AW; Wiggers T; Kirkels WJ; Eggermont AM; de Wilt JH
    Eur J Surg Oncol; 2007 May; 33(4):452-8. PubMed ID: 17071043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative outcome between chemoradiotherapy and lateral pelvic lymph node dissection following total mesorectal excision in rectal cancer.
    Kim JC; Takahashi K; Yu CS; Kim HC; Kim TW; Ryu MH; Kim JH; Mori T
    Ann Surg; 2007 Nov; 246(5):754-62. PubMed ID: 17968166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Laparoscopic pelvic autonomic nerve-preserving surgery for patients with lower rectal cancer after chemoradiation therapy.
    Liang JT; Lai HS; Lee PH
    Ann Surg Oncol; 2007 Apr; 14(4):1285-7. PubMed ID: 17235719
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adjuvant chemotherapy with uracil-tegafur for pathological stage III rectal cancer after mesorectal excision with selective lateral pelvic lymphadenectomy: a multicenter randomized controlled trial.
    Akasu T; Moriya Y; Ohashi Y; Yoshida S; Shirao K; Kodaira S;
    Jpn J Clin Oncol; 2006 Apr; 36(4):237-44. PubMed ID: 16675478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The significance of tumor markers for proliferation and apoptosis in predicting survival in colorectal cancer.
    Hilska M; Collan YU; O Laine VJ; Kössi J; Hirsimäki P; Laato M; Roberts PJ
    Dis Colon Rectum; 2005 Dec; 48(12):2197-208. PubMed ID: 16400510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [CT-guided radiofrequency ablation therapy for pelvic recurrence from rectal carcinoma--a case report].
    Nakano D; Matsumoto H; Yamaguchi T; Iwasaki Y; Ohashi M; Nunobe S; Iwanaga T; Takahashi K; Mori T
    Gan To Kagaku Ryoho; 2008 Nov; 35(12):2156-8. PubMed ID: 19106555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of prognosis and surgical indications for pulmonary metastasectomy from colorectal cancer.
    Iizasa T; Suzuki M; Yoshida S; Motohashi S; Yasufuku K; Iyoda A; Shibuya K; Hiroshima K; Nakatani Y; Fujisawa T
    Ann Thorac Surg; 2006 Jul; 82(1):254-60. PubMed ID: 16798225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction of treatment outcome by CD44v6 after total mesorectal excision in locally advanced rectal cancer.
    Peng J; Lu JJ; Zhu J; Xu Y; Lu H; Lian P; Cai G; Cai S
    Cancer J; 2008; 14(1):54-61. PubMed ID: 18303484
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor markers in staging and prognosis of colorectal carcinoma.
    Levy M; Visokai V; Lipska L; Topolcan O
    Neoplasma; 2008; 55(2):138-42. PubMed ID: 18237252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Late pelvic recurrence of rectal cancer].
    Walz MK; Molls M; Schmidt U; Eigler FW
    Chirurg; 1993 Apr; 64(4):353-5. PubMed ID: 7683261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of recurrence in patients with T2 and early T3, N0 adenocarcinoma of the rectum treated by surgery alone.
    Nissan A; Stojadinovic A; Shia J; Hoos A; Guillem JG; Klimstra D; Cohen AM; Minsky BD; Paty PB; Wong WD
    J Clin Oncol; 2006 Sep; 24(25):4078-84. PubMed ID: 16943525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Local recurrences of rectal cancer.
    Roncucci L
    Minerva Chir; 2005 Jun; 60(3):167-78. PubMed ID: 15985992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adjuvant radiochemotherapy of stage II and III rectal adenocarcinoma: role of CEA and CA 19-9.
    Weissenberger C; Von Plehn G; Otto F; Barke A; Momm F; Geissler M
    Anticancer Res; 2005; 25(3A):1787-93. PubMed ID: 16033101
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prognostic study of preoperative serum levels of CEA and CA 19-9 in colorectal cancer].
    Uehara M; Manaka D; Baba S; Oji Y; Hirata K; Shimizu M; Noguchi M
    Gan To Kagaku Ryoho; 2007 Sep; 34(9):1413-7. PubMed ID: 17876139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcomes of resection of stage IV rectal cancer with mesorectal excision.
    Law WL; Chu KW
    J Surg Oncol; 2006 Jun; 93(7):523-8. PubMed ID: 16705728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efforts to improve local control in rectal cancer compromise survival by the potential morbidity of optimal mesorectal excision.
    Laurent C; Nobili S; Rullier A; Vendrely V; Saric J; Rullier E
    J Am Coll Surg; 2006 Nov; 203(5):684-91. PubMed ID: 17084330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [CT-guided radiofrequency ablation of liver metastases from colorectal cancer].
    Mahnken AH; Bruners P; Tacke JA; Günther RW
    Dtsch Med Wochenschr; 2009 May; 134(19):976-80. PubMed ID: 19401962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of adjuvant radiotherapy on local recurrence in stage II rectal cancer.
    Park IJ; Kim HC; Yu CS; Kim TW; Jang SJ; Kim JC
    Ann Surg Oncol; 2008 Feb; 15(2):519-25. PubMed ID: 17960464
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Results of local ablation therapy for liver metastases from colorectal cancer using radiofrequency ablation and microwave coagulation therapy (RFA/MCT)].
    Yoshitani S; Hayashi K; Kuroda M; Tanaka Y; Hasegawa T; Saito H; Kosaka T; Takashima S
    Gan To Kagaku Ryoho; 2005 Oct; 32(11):1666-9. PubMed ID: 16315903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.